Repros Theraup (NASDAQ:RPRX)
A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
sracster
(56.11)
Submitted: 5/22/2013 3:06:05 PM :
Start Price:
$16.01
RPRX Score:
-2.57
VV Hindenburg
Recs
NuclearSteve
(55.83)
Submitted: 4/12/2013 2:04:01 PM :
Start Price:
$17.12
RPRX Score:
-7.86
Another Baker brothers holding I want for the long term.
Recs
TMFBlacknGold
(99.37)
Submitted: 12/21/2012 9:34:30 AM :
Start Price:
$9.14
RPRX Score:
-59.07
I fought the run-up and the, run-up won.
Recs
TMFCop
(85.09)
Submitted: 9/20/2012 8:51:15 AM :
Start Price:
$15.96
RPRX Score:
-9.82
A short term pick. RPRX is set to update trials in the fourth quarter and report results early next year. I'm expecting the updates to be positive, though the ultimate results remain foggy. So with a catalyst for a bounce later on, I'm weighing in here with an outperform.
Recs
jwray01
(99.63)
Submitted: 8/21/2012 12:05:14 PM :
Start Price:
$11.11
RPRX Score:
-32.51
Seen on stock spam newsletters yesterday. Inexplicable volume and price spike yesterday in the absence of any relevant news.
Recs
liszewski
(99.96)
Submitted: 10/21/2011 11:20:37 PM :
Start Price:
$4.03
RPRX Score:
-276.30
Zonagen. lol.
Recs
rodessa
(23.83)
Submitted: 7/26/2011 7:12:18 AM :
Start Price:
$6.52
RPRX Score:
-129.46
This company should take the same way as CBLI in the coming weeks as nothing at all can justify it's actual market price.To short without any moderation!!!
Recs
bridgeboy0
(99.82)
Submitted: 2/4/2011 12:27:17 PM :
Start Price:
$3.30
RPRX Score:
-373.52
From goldminingXpert
Recs
goldminingXpert
(30.95)
Submitted: 2/3/2011 1:25:49 PM :
Start Price:
$2.53
RPRX Score:
-525.36
Still broke, still no drug. The Zonagen saga continues...
Recs
ravens9111
(61.07)
Submitted: 12/24/2010 12:45:17 AM :
Start Price:
$1.44
RPRX Score:
+1,014.26
Might be late to the party but I think even if it pulls back there is still more upside here.
Recs
panochey
(< 20)
Submitted: 1/19/2009 8:42:52 AM :
Start Price:
$45.96
RPRX Score:
-163.69
Repros Therapeutics Inc. Announces That Proellex Significantly Reduced Pain in a U.S. Phase 2 Clinical Trial (Jan 2009)
Anything that helps Momma with the monthlies is gonna sell well. Oh, and minimal debt.
Recs
smallcapinvest
(89.65)
Submitted: 12/17/2008 11:14:11 AM :
Start Price:
$42.52
RPRX Score:
-148.10
little gamble since fundamentals are so bad, but MACD looks good, STO is converging and I am hoping for a crossover
Recs
SanDieguito
(< 20)
Submitted: 12/3/2007 3:08:08 PM :
Start Price:
$30.60
RPRX Score:
+63.56
down $2 to $7
Recs
ProphetOfProfits
(40.06)
Submitted: 7/27/2007 10:59:02 AM :
Start Price:
$52.80
RPRX Score:
-86.90
Good clinical data re Proellex safety is a good enough reason for me to hop in again
Recs
jbfoolsgold
(< 20)
Submitted: 7/17/2007 10:47:22 PM :
Start Price:
$52.64
RPRX Score:
-81.48
Strong development pipeline, product potentials and buyout potentials. It is just a matter of time before something happens to push to $20.
Recs
Molucre
(81.68)
Submitted: 2/15/2007 6:27:13 PM :
Start Price:
$43.80
RPRX Score:
-82.97
Blockbuster drug with excellent Phase II data. Company will be bought out before the end of Phase III.
Recs
foolphighter
(< 20)
Submitted: 1/12/2007 1:46:41 AM :
Start Price:
$48.96
RPRX Score:
-89.76
Micro biotech recently announced statistically significant results for its lead drug Proellex in two different indications and non-inferiority in another drug, Androxal.
with only 10M shares o/s, and just under a $1/share in cash, a financing appears to be in the company's near term future, but given the recent run-up in price, the dilution should help increase liquidity & institutional ownership while making it fairly painless for current shareholders. good speculative bet over the next 12 to 24 months.
Recs
BongoBilly
(< 20)
Submitted: 12/27/2006 7:13:26 AM :
Start Price:
$47.40
RPRX Score:
-88.86
Significantly undervalued south of $25
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 18 of 18